SEIS / EIS
SEIS Loss Relief: How It Works and How to Claim
How SEIS loss relief is calculated, when a negligible-value claim may help, claim deadlines and worked examples after income tax relief.
SEIS / EIS
How SEIS loss relief is calculated, when a negligible-value claim may help, claim deadlines and worked examples after income tax relief.
SEIS / EIS
Understand SEIS reinvestment relief, the disposal exemption, carry-back timing and how these differ from EIS capital gains deferral.
SEIS / EIS
SEIS and EIS for software and SaaS companies: IP ownership, licence income, risk to capital, knowledge-intensive status and funding applications.
SEIS / EIS
How pre-revenue and loss-making biotech companies can use SEIS and EIS: R&D activity, KIC status, sequencing, financial health and investor losses.
Enterprise Management Incentives
How SEIS, EIS and EMI work together: share rights, optional HMRC valuation agreement, founder interests, funding sequence and employee buybacks.
SEIS / EIS
HMRC's VCR Team refused your SEIS or EIS advance assurance? Learn why advance assurance gets rejected and how to fix the issue before reapplying.
SEIS / EIS
Can a director claim SEIS or EIS? Check paid and unpaid directors, the business-angel exception, historic holdings, associates and follow-on investment.
SEIS / EIS
Understand the SEIS and EIS risk-to-capital condition: long-term growth, commercial loss, recurring revenue, assets, outsourcing and application evidence.
SEIS / EIS
Can a US parent or its UK subsidiary raise EIS? Check issuer independence, UK permanent establishment, group history and restructuring options.
SEIS / EIS
Plan multiple SEIS and EIS rounds: different-day share issues, current limits, follow-on funding, age rules, use of money and compliance statements.
SEIS / EIS
Check EIS financial health at the share issue: accumulated losses, capital, evidence, SEIS rules and the consequences of an HMRC challenge.
SEIS / EIS
SEIS investor eligibility explained: employee and director rules, associates, historic substantial interests, subscriber shares and why dilution may not help.